FDA Expands Casgevy for Children 2+ with Sickle Cell Disease
The FDA approved the first gene therapy for children as young as 2 years old with sickle cell disease or transfusion-dependent beta thalassemia.
Category: Products & Treatment
Products & Treatment
Latest
Products & Treatment
Latest
Dynarex Launches POC, Neo/Pediatric Closed Suction Catheters
Dynarex Corp launched a new Resp-O₂ Portable Oxygen Concentrator and a new line of infant- and pediatric-sized closed suction catheters.
Products & Treatment
Latest
Capnography and Pulse Oximetry in the PICU
For patients in the pediatric ICU, pulse oximetry and waveform capnography are valuable tools to monitor the effectiveness of respiratory support and to inform treatment decisions.
Industry & Regulatory News
Latest
FDA Approves Generic Xofluza
The FDA approved the first generic of Xofluza (baloxavir marboxil) tablets, the first single-dose treatment for acute uncomplicated influenza and prophylaxis in patients 5 years of age and older.
Pharmaceuticals
Latest
Unique Attack Method for New Antibiotic
Researchers discovered manikomycin, a soil-derived peptide that attacks bacteria in a unique way to bypass existing antibiotic resistance.
Diagnostics & Testing
Latest
First Endobronchial Ultrasound Procedure at New Jersey Medical Center
Hackensack Meridian Pascack Valley Medical Center successfully completed its first endobronchial ultrasound to diagnose pulmonary conditions.
Monitoring & Treatment
Latest
BreatheLink Mobile App for Overnight Oximetry Testing
The BreatheLink platform allows patients to transmit overnight oximetry data from their own smartphones, reducing the time required to set up home oxygen therapy.